Journal of Pharmacology and Pharmacotherapeutics

CASE REPORT
Year
: 2017  |  Volume : 8  |  Issue : 1  |  Page : 35--37

Severe bone marrow suppression accompanying pulmonary infection and hemorrhage of the digestive tract associated with leflunomide and low-dose methotrexate combination therapy


Caihong Qu1, Ying Lu2, Weimin Liu3 
1 Department of Clinical Pharmacy, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
2 Department of Internal Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
3 Department of Radiology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

Correspondence Address:
Caihong Qu
Department of Clinical Pharmacy, The Third Affiliated Hospital of Sun Yat.Sen University, 600 Tianhe Road, Tianhe District, Guangzhou 510630, Guangdong Province
China

A 60-year-old male patient developed hyperpyrexia, cough, expectoration with blood-stained sputum, mouth ulcers, and suppurative tonsillitis after receiving 35 days of combination treatment with leflunomide (LEF) and low-dose methotrexate (MTX) for active rheumatoid arthritis. On admission, routine blood tests showed severe thrombocytopenia, agranulocytosis, and decreased hemoglobin concentration compared with the relatively normal results of 1 month previously during the first hospitalization. Chest radiography revealed inflammation in both lungs, and a fecal occult blood test was positive. Given this presentation, severe bone marrow suppression accompanying pulmonary infection and hemorrhage of the digestive tract associated with LEF and MTX combination therapy was diagnosed. After 28 days of symptomatic treatment, the patient's complications subsided gradually. This case highlighted that bone marrow suppression associated with MTX and LEF combination therapy could be very serious, even at a normal dose or especially at the beginning of treatment. MTX and LEF combination therapy should be used with caution or be limited in those with a history of pulmonary disease, hemorrhage of the digestive tract, or other relevant diseases.


How to cite this article:
Qu C, Lu Y, Liu W. Severe bone marrow suppression accompanying pulmonary infection and hemorrhage of the digestive tract associated with leflunomide and low-dose methotrexate combination therapy.J Pharmacol Pharmacother 2017;8:35-37


How to cite this URL:
Qu C, Lu Y, Liu W. Severe bone marrow suppression accompanying pulmonary infection and hemorrhage of the digestive tract associated with leflunomide and low-dose methotrexate combination therapy. J Pharmacol Pharmacother [serial online] 2017 [cited 2020 Sep 24 ];8:35-37
Available from: http://www.jpharmacol.com/article.asp?issn=0976-500X;year=2017;volume=8;issue=1;spage=35;epage=37;aulast=Qu;type=0